CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Shine-On BioMedical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Shine-On BioMedical Co Ltd
Phone: +886 423272888p:+886 423272888 TAICHUNG, 407  Taiwan Ticker: 69266926
Business Summary
Shine-On BioMedical Co Ltd is a Taiwan-based company mainly engaged in the research, development and manufacture of anti-cancer related new drug products. Antibody products include trispecific T cell engaging nanobody (SOA101), EphA10 trispecific antibody engaging immune cells (SOA201), iNb Intrabody nanoscale intracellular specific antibody drug (SOA102), iNb STAR TriTE T cell receptor Nano-scale trispecific antibody drug (SOA103). Nucleic acid drugs include exosome-carrying nucleic acid and chemotherapy drugs (SOB101).
(Source: N-30D)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Deputy General Manager-R&D HuijunHe 1/3/2023 1/3/2023
Head of Finance & Accounting YunruChen 3/9/2023 3/9/2023

General Information
Number of Employees: 19 (As of 12/31/2023)
Outstanding Shares: 49,800,000 (As of 12/31/2023)
Stock Exchange: TPO
Fax Number: +886 423272666


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, April 27, 2024